Why today is a big day for Pro Medicus shares

Records are being broken by this share on Monday. What's going on?

| More on:
Excited group of friends sitting on sofa watching sports on TV and celebrating.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares have continued their record-breaking run on Monday.

In morning trade, the health imaging technology company's shares have risen over 2% to a record high of $226.79.

This means that its shares are now up a staggering 160% since this time last year.

Why are Pro Medicus shares breaking records today?

Investors have been buying the company's shares this morning following the release of its annual general meeting presentation before the main event.

While that presentation focused a lot of what happened in FY 2024, there was also commentary on the future that appears to have got investors excited.

But let's start with a look at the last financial year. Commenting on the 12 months, Pro Medicus' chair, Peter Kempen, said:

FY2024 was another record year for the company with revenue increasing by 29.3% to $161.5 million and net profit after tax increasing by 36.5% to $82.8 million. The Company continued to be cash flow positive with retained cash and liquid investments increasing from $121.5 million to $155.4 million, after a A$2.77m buyback of shares in February/March, a $US5m investment in cardiac CT AI company Elucid and paying increased dividends.

Pleasingly, Kempen then stated that "the Board anticipates FY25 will be another strong year." He then adds:

The budget for the current financial year has been determined recognising anticipated continuing strong growth, from both existing and new clients. I am pleased to advise that results to date are ahead of budget on a constant currency basis and an Australian dollar basis, despite some volatility in currency markets during the period. We anticipate that the second half of the financial year will be stronger than the first half, as is traditionally the case.

Big future

Also giving Pro Medicus shares a boost is likely to be a part of its presentation which focuses on its total addressable market (TAM).

The company notes that it has a huge TAM in the United States. It highlights that there are 650 million exams performed each year and this is growing by 2% to 3% per annum.

It points out that Pro Medicus' best in class Visage platform is able to address 100% of this TAM from a product perspective and 85% from a commercial perspective.

Whereas at present, its current penetration is just a modest but lucrative 7%. It believes this provides it with a "large addressable runway." Management also sees opportunities to leverage artificial intelligence to drive further growth.

All in all, the future looks bright for Pro Medicus and its shares.

Should you invest $1,000 in Pro Medicus right now?

Before you buy Pro Medicus shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Pro Medicus wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Technology Shares

3 reasons to buy this $25 billion ASX 200 tech stock today

A top expert forecasts more outperformance from this fast-growing ASX 200 tech stock.

Read more »

Lines of codes and graphs in the background with woman looking at laptop trying to understand the data.
Technology Shares

Why is the Brainchip share price crashing 9% today?

The semiconductor company is being sold off on Tuesday. But why?

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Technology Shares

3 reasons this sold-off ASX 200 share is primed for a big rebound

A leading expert believes this ASX 200 share is well placed to outperform.

Read more »

a man surrounded by huge piles of paper looks through a magnifying glass at his computer screen.
Technology Shares

I did some research on Siteminder — Here's what you should know

The big questions I'm monitoring for answers.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Technology Shares

Up 98% in a year, how this ASX All Ords stock is tapping into a $16 billion market

A leading expert forecasts more outsized returns for this surging ASX All Ords stock.

Read more »

Man with rocket wings which have flames coming out of them.
Technology Shares

Guess which ASX All Ords stock is rocketing 34% on takeover deal

This stock looks set to leave the ASX boards in the near future after accepting a takeover deal.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Technology Shares

Are DroneShield shares going to $1.50?

Where next for this high-flying stock? Let's see what Bell Potter is saying.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Technology Shares

DroneShield shares jump on record-breaking quarter

It was an impressive three months for this counter drone technology company.

Read more »